Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
|
| gptkbp:ATCCode |
J01FA06
|
| gptkbp:brand |
Rulide
Surlid |
| gptkbp:CASNumber |
80214-83-1
|
| gptkbp:chemicalClass |
macrolide
|
| gptkbp:contraindication |
hypersensitivity to macrolides
|
| gptkbp:discoveredBy |
gptkb:Hoechst_AG
|
| gptkbp:eliminationHalfLife |
12 hours
|
| gptkbp:excretion |
urine
bile |
| gptkbp:hasMolecularFormula |
C41H76N2O15
|
| https://www.w3.org/2000/01/rdf-schema#label |
roxithromycin
|
| gptkbp:introducedIn |
1987
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits protein synthesis
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
B1 (Australia)
|
| gptkbp:proteinBinding |
96%
|
| gptkbp:relatedTo |
gptkb:erythromycin
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
headache
rash gastrointestinal upset |
| gptkbp:usedFor |
bacterial infections
|
| gptkbp:bfsParent |
gptkb:Erythromycin
gptkb:Macrolides |
| gptkbp:bfsLayer |
5
|